Off The WHO Hook, Sanofi CEO Viehbacher Plans To Take Shantha's Vaccines To The World
This article was originally published in PharmAsia News
Executive Summary
HYDERABAD, India - Shantha Biotechnics, the Sanofi-owned Indian vaccines company, has received prequalification by the World Health Organization for a range of vaccines, including the pentavalent Shan 5 vaccine brand that had been previously disqualified by the world agency following detection of impurities in some batches